Effectiveness of a Culturally Adapted Online Education Program (iSupport-Korea) for Family Caregi… (NCT07609316) | Clinical Trial Compass
RecruitingNot Applicable
Effectiveness of a Culturally Adapted Online Education Program (iSupport-Korea) for Family Caregivers of People With Dementia
South Korea160 participantsStarted 2026-05-13
Plain-language summary
This randomized controlled trial evaluates the effectiveness of iSupport-Korea, a culturally adapted online education program for family caregivers of people with dementia. A total of 160 caregivers will be randomly assigned to either the intervention or control group and followed for 4 months. The investigators hypothesize that the intervention group will show greater improvements in care-related quality of life, caregiver self-efficacy, and family decision-making self-efficacy.
Who can participate
Age range
19 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 19 years or older
* Family caregivers currently providing care for a person diagnosed with dementia
* Informal caregivers such as spouse, children, or relatives
* Living with the person with dementia or providing regular care even if not cohabiting
* Able to read and understand Korean and communicate in Korean
* Able to use digital devices (e.g., smartphone, tablet, or computer) to access an online program
* Willing to provide informed consent and participate in the study
Exclusion Criteria:
* Not currently providing direct care to a person with dementia
* Participating in another dementia caregiver intervention or similar study
* Having severe cognitive impairment, psychiatric illness, or communication difficulties that limit participation
* Having severe visual or hearing impairment that interferes with program use
* Unable to complete follow-up assessments during the study period
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in subjective well-being (CarerQol-VAS)
Timeframe: Baseline, 2 months, and 4 months
2
Change in care-related quality of life (CarerQol-7D)